Amplia Therapeutics Ltd.ASX: ATX

Nucleus Network Appointed to Conduct Phase 1 Clinical Trial

Jul 23, 2020 at 2:57 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment